DXCM vs NIQ · P/E 63, rev $2.50B vs rev $4.20B
DexCom Inc (DXCM) versus NIQ Global Intelligence plc (NIQ) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
NIQ Global Intelligence plc (NIQ) common stock listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported NIQ revenue for 2025-12-31 was $4.20B. Net income was -$353.3M. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. NIQ currently screens at market cap $2.53B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. NIQ currently screens at market cap $2.53B.
Not investment advice. Open the DXCM and NIQ stock pages for the full models.
Not investment advice.